Authors:
Altamura, AC
Bassetti, R
Sassella, F
Salvadori, D
Mundo, E
Citation: Ac. Altamura et al., Duration of untreated psychosis as a predictor of outcome in first-episodeschizophrenia: a retrospective study, SCHIZOPHR R, 52(1-2), 2001, pp. 29-36
Authors:
Altamura, AC
Bobes, J
Owens, DC
Gerlach, J
Hellewell, JSE
Kasper, S
Naber, D
Tarrier, N
Van Os, J
Citation: Ac. Altamura et al., Schizophrenia: diagnosis and continuing treatment - principles of practicefrom the European expert panel on the contemporary treatment of schizophrenia, INT J PSYC, 4, 2000, pp. S1-S11
Citation: Ac. Altamura et Sr. Bareggi, Comment on 'Reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia', INT CLIN PS, 15(5), 2000, pp. 303-303
Citation: Ac. Altamura et al., HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment, EUR NEUROPS, 10(1), 1999, pp. 1-4
Citation: Ac. Altamura et al., Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders, INT CLIN PS, 14(4), 1999, pp. 239-245
Authors:
Percudani, M
Fattore, G
Galletta, J
Mita, PL
Contini, A
Altamura, AC
Citation: M. Percudani et al., Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy, ACT PSYC SC, 99(4), 1999, pp. 274-280
Authors:
Altamura, AC
Carta, MG
Tacchini, G
Musazzi, A
Pioli, MR
Citation: Ac. Altamura et al., Prevalence of somatoform disorders in a psychiatric population: an Italiannationwide survey, EUR ARCH PS, 248(6), 1998, pp. 267-271